|Bid||0.0000 x 2900|
|Ask||0.0000 x 1400|
|Day's range||2.9300 - 3.0700|
|52-week range||2.9300 - 33.9000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||15 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.50|
Insiders who acquired US$6.4m worth of Talis Biomedical Corporation's ( NASDAQ:TLIS ) stock at an average price of...
BENSALEM, Pa., December 09, 2021--Law Offices of Howard G. Smith continues its investigation on behalf of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) investors concerning the Company’s possible violations of the federal securities laws.
LOS ANGELES, December 08, 2021--The Law Offices of Frank R. Cruz Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors